ADPT logo

Adaptive Biotechnologies (ADPT) Cash From Operations

Annual CFO

-$95.21 M
+$61.11 M+39.09%

December 1, 2024


Summary


Performance

ADPT Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherADPTcash flowmetrics:

Quarterly CFO

-$12.49 M
+$14.57 M+53.85%

December 1, 2024


Summary


Performance

ADPT Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherADPTcash flowmetrics:

TTM CFO

-$95.21 M
+$14.44 M+13.17%

December 1, 2024


Summary


Performance

ADPT TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherADPTcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ADPT Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+39.1%+53.9%+13.2%
3 y3 years+50.6%+73.5%+54.4%
5 y5 years-146.3%+73.5%+54.4%

ADPT Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+50.6%at high+80.6%at high+54.4%
5 y5-year-146.3%+50.6%at high+80.6%-146.3%+54.4%
alltimeall time-146.3%+50.6%-104.5%+80.6%-137.8%+54.4%

Adaptive Biotechnologies Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
-$95.21 M(-39.1%)
-$12.49 M(-53.8%)
-$95.21 M(-13.2%)
Sep 2024
-
-$27.07 M(+56.4%)
-$109.65 M(-15.2%)
Jun 2024
-
-$17.30 M(-54.9%)
-$129.27 M(-4.6%)
Mar 2024
-
-$38.35 M(+42.4%)
-$135.53 M(-13.3%)
Dec 2023
-$156.32 M(-15.0%)
-$26.93 M(-42.3%)
-$156.32 M(-1.9%)
Sep 2023
-
-$46.68 M(+98.2%)
-$159.41 M(+2.8%)
Jun 2023
-
-$23.56 M(-60.2%)
-$155.13 M(-13.2%)
Mar 2023
-
-$59.15 M(+97.0%)
-$178.64 M(-2.9%)
Dec 2022
-$183.94 M(-4.6%)
-$30.02 M(-29.2%)
-$183.94 M(-11.5%)
Sep 2022
-
-$42.41 M(-9.9%)
-$207.75 M(-0.5%)
Jun 2022
-
-$47.06 M(-27.0%)
-$208.79 M(+5.0%)
Mar 2022
-
-$64.45 M(+19.7%)
-$198.94 M(+3.2%)
Dec 2021
-$192.73 M
-$53.83 M(+23.9%)
-$192.73 M(+7.8%)
Sep 2021
-
-$43.44 M(+16.7%)
-$178.75 M(-2.0%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$37.21 M(-36.1%)
-$182.46 M(+3.5%)
Mar 2021
-
-$58.24 M(+46.2%)
-$176.32 M(+17.8%)
Dec 2020
-$149.68 M(-172.9%)
-$39.84 M(-15.5%)
-$149.68 M(+9.6%)
Sep 2020
-
-$47.16 M(+51.7%)
-$136.63 M(+14.2%)
Jun 2020
-
-$31.08 M(-1.7%)
-$119.61 M(+14.5%)
Mar 2020
-
-$31.61 M(+18.0%)
-$104.50 M(-150.9%)
Dec 2019
$205.40 M(-736.7%)
-$26.79 M(-11.1%)
$205.40 M(-9.4%)
Sep 2019
-
-$30.14 M(+88.7%)
$226.78 M(-7.5%)
Jun 2019
-
-$15.97 M(-105.7%)
$245.24 M(-2.7%)
Mar 2019
-
$278.30 M(-5244.2%)
$252.14 M(-881.6%)
Dec 2018
-$32.26 M(-7.5%)
-$5.41 M(-53.7%)
-$32.26 M(+20.1%)
Sep 2018
-
-$11.69 M(+28.9%)
-$26.85 M(+77.1%)
Jun 2018
-
-$9.07 M(+48.7%)
-$15.16 M(+148.7%)
Mar 2018
-
-$6.10 M
-$6.10 M
Dec 2017
-$34.86 M
-
-

FAQ

  • What is Adaptive Biotechnologies annual cash flow from operations?
  • What is the all time high annual CFO for Adaptive Biotechnologies?
  • What is Adaptive Biotechnologies annual CFO year-on-year change?
  • What is Adaptive Biotechnologies quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Adaptive Biotechnologies?
  • What is Adaptive Biotechnologies quarterly CFO year-on-year change?
  • What is Adaptive Biotechnologies TTM cash flow from operations?
  • What is the all time high TTM CFO for Adaptive Biotechnologies?
  • What is Adaptive Biotechnologies TTM CFO year-on-year change?

What is Adaptive Biotechnologies annual cash flow from operations?

The current annual CFO of ADPT is -$95.21 M

What is the all time high annual CFO for Adaptive Biotechnologies?

Adaptive Biotechnologies all-time high annual cash flow from operations is $205.40 M

What is Adaptive Biotechnologies annual CFO year-on-year change?

Over the past year, ADPT annual cash flow from operations has changed by +$61.11 M (+39.09%)

What is Adaptive Biotechnologies quarterly cash flow from operations?

The current quarterly CFO of ADPT is -$12.49 M

What is the all time high quarterly CFO for Adaptive Biotechnologies?

Adaptive Biotechnologies all-time high quarterly cash flow from operations is $278.30 M

What is Adaptive Biotechnologies quarterly CFO year-on-year change?

Over the past year, ADPT quarterly cash flow from operations has changed by +$14.57 M (+53.85%)

What is Adaptive Biotechnologies TTM cash flow from operations?

The current TTM CFO of ADPT is -$95.21 M

What is the all time high TTM CFO for Adaptive Biotechnologies?

Adaptive Biotechnologies all-time high TTM cash flow from operations is $252.14 M

What is Adaptive Biotechnologies TTM CFO year-on-year change?

Over the past year, ADPT TTM cash flow from operations has changed by +$14.44 M (+13.17%)